Jianmei Pang - Concepedia

Author

Jianmei Pang

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

J Pang, J Y Pang, JIAN-MEI PANG, Jian-Mei Pang, JianMei Pang, Jianmei Pang, Luan, Pang, Jianmei, Renyun Wang

Publications

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Shandong University Chinese Academy of Medical Sciences & Peking Union Medical College

About

Jianmei Pang is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	554
2	Biochemistry	10	11	496
3	Natural Sciences	5	5	253
4	Engineering	1	1	18
5	Biomolecular Engineering	1	1	28

Jianmei Pang

Publications

955

Citations

H-Index

Page 1

	Year	Citations
Studies on Cytochrome P-450-Mediated Bioactivation of Diclofenac in Rats and in Human Hepatocytes: Identification of Glutathione Conjugated Metabolites Wei Tang, Ralph A. Stearns, Stelvio M. Bandiera, Drug Metabolism and Disposition	1999	170
Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors Scott D. Edmondson, Lan Wei, Jinyou Xu, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBioorganic ChemistryBiochemistryNatural SciencesMedicine	2008	106
Determination ofin vitro permeability of drug candidates through a Caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry Zhen Wang, Cornelis E. C. A. Hop, Kwan Leung, Journal of Mass Spectrometry Pharmaceutical ScienceGlycobiologyHplc ColumnGas ChromatographyDrug Purity	2000	102
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity Iyassu K. Sebhat, Christopher S. Franklin, Michael M.‐C. Lo, ACS Medicinal Chemistry Letters ObesityCompound 22BiochemistryFunctional SelectivityMedicine	2010	65
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity Harry R. Chobanian, Yan Guo, Ping Liu, ACS Medicinal Chemistry Letters	2012	61
Folate-conjugated hybrid SBA-15 particles for targeted anticancer drug delivery Jianmei Pang, Lanxia Zhao, Longlong Zhang, Journal of Colloid and Interface Science NanomedicineDrug TargetingPolymer-drug ConjugateMedicineDrug Delivery Systems	2012	58
Discovery of <i>N</i>-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1–3 (HIF PHD1–3) for the Treatment of Anemia John S. Debenham, Christina B. Madsen-Duggan, Matthew J. Clements, Journal of Medicinal Chemistry Po AdministrationPharmacotherapyRedox BiologyOxidative StressMolecular Pharmacology	2016	54
A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment Daniel Tatosian, Ka Lai Yee, Zufei Zhang, Clinical Pharmacology & Therapeutics	2020	52
Investigation on the Enzymatic Profile of Mulberry Alkaloids by Enzymatic Study and Molecular Docking Zhihua Liu, Ying Yang, Wujun Dong, Molecules	2019	45
Discovery of Benzodiazepine Sulfonamide-Based Bombesin Receptor Subtype 3 Agonists and Their Unusual Chirality Ping Liu, Thomas J. Lanza, Marc Chioda, ACS Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryBiochemistrySeven-membered Diazepine RingNatural Sciences	2011	43

Page 1